ArticleClinical and translational science2023

Characterizing complex and competing drug-drug interactions between the antiviral regimen of glecaprevir and pibrentasvir with rifampin or carbamazepine.

Matthew P Kosloski et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.